NF PROTOCOL 108: A Phase II Study of Binimetinib in Children and Adults with NF1 associated Plexiform Neurofibromas (PNOC010)

Brief description of study

If you have been diagnosed with NF1 associated Plexiform Neurofibromas, you or your child may qualify for this Phase II study. The main goal of this study is to see if the drug binimetinib is safe and effective in treating patients who have NF1 associated Plexiform Neurofibromas.


Clinical Study Identifier: s18-00194
ClinicalTrials.gov Identifier: NCT03231306
Principal Investigator: Jeffrey C Allen
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.